RT Journal Article
SR Electronic
A1 Mosely, Mary
T1 CV Protection by Antihyperglycemic Drugs: Evidence from Clinical Trials
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 9
SP 14
OP 15
DO 10.1177/155989771309011
UL http://mdc.sagepub.com/content/13/9/14.abstract
AB This article discusses the evidence from clinical trials addressing the reduction of cardiovascular (CV) risk with antihyperglycemic drugs. Specific trials include the UKPDS, ACCORD, RECORD, NAVIGATOR, and ORIGIN trials, as well as a number of ongoing clinical trials examining the CV safety of dipeptidyl peptidase-4 inhibitors.